Ticker
ARVNCompany Name
ARVINAS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Capital Expenditure | Capital Expenditures Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 2.6M | 0.7% | $ 372.8M |
3/31/2025 | $ 2M | 0.47% | $ 426.9M |
12/31/2024 | $ 1.7M | 0.65% | $ 263.4M |
9/30/2024 | $ 1.5M | 0.93% | $ 161.1M |
6/30/2024 | $ 1.9M | 2.04% | $ 93.3M |
3/31/2024 | $ 1.9M | 2.66% | $ 71.3M |
12/31/2023 | $ 2.9M | 3.69% | $ 78.5M |
9/30/2023 | $ 3.9M | 2.33% | $ 167.2M |
6/30/2023 | $ 5M | 3.07% | $ 162.9M |
3/31/2023 | $ 5.8M | 4.15% | $ 139.7M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CapEx / Revenues
(=) CapEx %
CapEx % for ARVINAS INC is calculated as follows: CapEx [ $ 6.38M ] / Revenues [ $ 24.48M ]
(=) CapEx % [ 26.07% ]
Minimum
Mar 31, 2025
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 2.85K |
---|---|
min | 0% |
max | 15.04% |
average | 3.46% |
median | 2.43% |
std | 3.27% |